Canada this Thursday authorized the use of Moderna’s Spikevax Bivalent, the first vaccine developed specifically against the micron variant of the virus. COVID-19-19 but that it is also effective against the original strain of the virus.
Ministry of Health care Canada authorized the use of a bivalent vaccine in people over 18 and people aged 12 to 17 with “moderately” weakened immune systems.
August 22 pharmaceutical company modern announced that it would deliver a total of 12 million doses of bivalent vaccine to Ottawa, of which 1.5 million Canada this year.
Canadian Prime Minister Justin Trudeau made the announcement on Thursday. the first dose They will be distributed in the coming weeks.
Canadian health authorities said the new vaccine from modernthe first bivalent created against covid-19 is “essentially two vaccine in”.
“This will help us fight the next wave of disease,” said Dr. Supriya Sharma, director of medical advice. Canada.
A variant of omicron that is more contagious than the original strain of the virus and was discovered in Canada in November 2021 is responsible for the vast majority of cases COVID-19-19 currently registered in a North American country.
Spikevax Bivalent is the version vaccine messenger RNA (mRNA) that Moderna developed to fight the first variants of the coronavirus that causes COVID-19.
increased immunity
According to the information provided by the Ministry of Health CanadaSpikevax Bivalent offers a stronger immune response against the omicron BA.1 variant than vaccine original, in addition to creating a “good immune response” against sub-variants BA.4 and BA.5.
Canadian health authorities added that the protection of Spikevax Bivalent is expected to last longer than that of vaccine currently on the market.
Authorization for the use of Spikevax Bivalent is issued on the same day that the European Medicines Agency (EMA) unusually meets to review requests for pfizer D modern for authorization in Union European (EU) relevant vaccines adapted to options coronavirus what causes COVID-19-19.
EFE
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.